WallStreetZenWallStreetZen

NASDAQ: STIM
Neuronetics Inc Stock

$3.86+0.12 (+3.21%)
Updated Apr 23, 2024
STIM Price
$3.86
Fair Value Price
N/A
Market Cap
$114.86M
52 Week Low
$1.03
52 Week High
$5.07
P/E
-3.68x
P/B
3.36x
P/S
1.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$71.35M
Earnings
-$30.19M
Gross Margin
72.5%
Operating Margin
-34.71%
Profit Margin
-42.3%
Debt to Equity
2.39
Operating Cash Flow
-$32M
Beta
1.29
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

STIM Overview

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how STIM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

STIM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
STIM is good value based on its book value relative to its share price (3.36x), compared to the US Diagnostics & Research industry average (4.24x)
P/B vs Industry Valuation
STIM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more STIM due diligence checks available for Premium users.

Be the first to know about important STIM news, forecast changes, insider trades & much more!

STIM News

Valuation

STIM fair value

Fair Value of STIM stock based on Discounted Cash Flow (DCF)
Price
$3.86
Fair Value
$5.43
Undervalued by
28.88%
STIM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

STIM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.68x
Industry
38.97x
Market
41.92x

STIM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.36x
Industry
4.24x
STIM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

STIM's financial health

Profit margin

Revenue
$20.3M
Net Income
-$5.4M
Profit Margin
-26.5%
STIM's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
STIM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$115.8M
Liabilities
$81.6M
Debt to equity
2.39
STIM's short-term assets ($93.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
STIM's short-term assets ($93.79M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
STIM's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
STIM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$2.1M
Investing
-$563.0k
Financing
$22.3M
STIM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

STIM vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
STIM$114.86M+3.21%-3.68x3.36x
FONR$107.44M-1.17%8.47x0.66x
BDSX$124.09M-0.78%-2.00x27.09x
NOTV$125.08M+9.73%-3.73x0.49x
PRPH$93.11M+5.31%-5.27x1.89x

Neuronetics Stock FAQ

What is Neuronetics's quote symbol?

(NASDAQ: STIM) Neuronetics trades on the NASDAQ under the ticker symbol STIM. Neuronetics stock quotes can also be displayed as NASDAQ: STIM.

If you're new to stock investing, here's how to buy Neuronetics stock.

What is the 52 week high and low for Neuronetics (NASDAQ: STIM)?

(NASDAQ: STIM) Neuronetics's 52-week high was $5.07, and its 52-week low was $1.03. It is currently -23.87% from its 52-week high and 274.76% from its 52-week low.

How much is Neuronetics stock worth today?

(NASDAQ: STIM) Neuronetics currently has 29,756,053 outstanding shares. With Neuronetics stock trading at $3.86 per share, the total value of Neuronetics stock (market capitalization) is $114.86M.

Neuronetics stock was originally listed at a price of $27.78 in Jun 28, 2018. If you had invested in Neuronetics stock at $27.78, your return over the last 5 years would have been -86.11%, for an annualized return of -32.61% (not including any dividends or dividend reinvestments).

How much is Neuronetics's stock price per share?

(NASDAQ: STIM) Neuronetics stock price per share is $3.86 today (as of Apr 23, 2024).

What is Neuronetics's Market Cap?

(NASDAQ: STIM) Neuronetics's market cap is $114.86M, as of Apr 24, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neuronetics's market cap is calculated by multiplying STIM's current stock price of $3.86 by STIM's total outstanding shares of 29,756,053.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.